Get started
Author

Natsumi Inoue

Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis
2015 · Masaki Shimizu, Yasuo Nakagishi, et al. · Clinical Immunology · 180
Cytokine profile in adult-onset Still's disease: Comparison with systemic juvenile idiopathic arthritis
2016 · Natsumi Inoue, Masaki Shimizu, et al. · Clinical Immunology · 142
PDF
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial
2023 · Athimalaipet V Ramanan, Pierre Quartier, et al. · The Lancet · 97
Clinical significance of serum CXCL9 levels as a biomarker for systemic juvenile idiopathic arthritis associated macrophage activation syndrome
2019 · Mao Mizuta, Masaki Shimizu, et al. · Cytokine · 56
Cytokine profile of macrophage activation syndrome associated with Kawasaki disease
2019 · Asumi Jinkawa, Masaki Shimizu, et al. · Cytokine · 47
Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis
2017 · M Shimizu, N Inoue, et al. · Clinical & Experimental Immunology · 47
Serum ferritin levels as a useful diagnostic marker for the distinction of systemic juvenile idiopathic arthritis and Kawasaki disease
2016 · Mao Mizuta, Masaki Shimizu, et al. · Modern Rheumatology · 45
Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis
2018 · Naoto Sakumura, Masaki Shimizu, et al. · Cytokine · 44
Clinical significance of interleukin-18 for the diagnosis and prediction of disease course in systemic juvenile idiopathic arthritis
2020 · Mao Mizuta, Masaki Shimizu, et al. · Rheumatology · 40
Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children
2020 · Mao Mizuta, Masaki Shimizu, et al. · Rheumatology · 40
Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
2019 · Maiko Takakura, Masaki Shimizu, et al. · Clinical Immunology · 30
CD169 expression on monocytes as a marker for assessing type I interferon status in pediatric inflammatory diseases
2023 · Naoto Sakumura, Tadafumi Yokoyama, et al. · Clinical Immunology · 29
PDF
The critical role of lipopolysaccharide in the upregulation of aquaporin 4 in glial cells treated with Shiga toxin
2015 · Naotoshi Sugimoto, Hue Leu, et al. · Journal of Biomedical Science · 27
PDF
Extensive serum biomarker analysis in patients with macrophage activation syndrome associated with systemic lupus erythematosus
2019 · Masaaki Usami, Masaki Shimizu, et al. · Clinical Immunology · 23
Serum Leucine-Richα2-Glycoprotein as a Biomarker for Monitoring Disease Activity in Patients with Systemic Juvenile Idiopathic Arthritis
2019 · Masaki Shimizu, Natsumi Inoue, et al. · Journal of Immunology Research · 22
PDF
Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part one
2017 · F. De Benedetti, PRINTO/PRCSG, et al. · Pediatric Rheumatology · 21
PDF
Leopard skin appearance of cutaneous polyarteritis nodosa on18Ffluorodeoxyglucose positron emission tomography
2016 · Masaki Shimizu, Natsumi Inoue, et al. · Rheumatology · 21
Extensive serum biomarker analysis in patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome
2014 · Masaki Shimizu, Mondo Kuroda, et al. · Cytokine · 21
Leucine-rich α2-glycoprotein as the acute-phase reactant to detect systemic juvenile idiopathic arthritis disease activity during anti-interleukin-6 blockade therapy: A case series
2017 · Masaki Shimizu, Yasuo Nakagishi, et al. · Modern Rheumatology · 17
Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical Trial
2026 · Brendon L. Neuen, Vlado Perkovic, et al. · JAMA · 16
PDF
Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome
2023 · Natsumi Inoue, Grant S. Schulert · Arthritis Research & Therapy · 16
PDF
Apoptosis inhibitor of macrophage as a biomarker for disease activity in Japanese children with IgA nephropathy and Henoch–Schönlein purpura nephritis
2020 · Hitoshi Irabu, Masaki Shimizu, et al. · Pediatric Research · 15
Clinical significance of serum soluble TNF receptor II level and soluble TNF receptor II/I ratio as indicators of coronary artery lesion development in Kawasaki disease
2018 · Masaki Shimizu, Mao Mizuta, et al. · Cytokine · 14
Serum tau protein as a marker of disease activity in enterohemorrhagic Escherichia coli O111-induced hemolytic uremic syndrome
2015 · Mondo Kuroda, Masaki Shimizu, et al. · Neurochemistry International · 14
Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy
2020 · Hitoshi Irabu, Masaki Shimizu, et al. · Pediatric Research · 13
Works count: 79
Citation count: 1,254
H-index: 20
I10-index: 30
Year
Topic
Type